Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitisinone for Oculocutaneous Albinism Type 1B
NCT01838655Phase 2Completed
- Sponsor
- National Eye Institute
- Start
- Apr 2013
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nitisinone in oculocutaneous albinism type 1B (OCA1B), sponsored by National Eye Institute. Started Apr 2013; status: completed.
02
Drugs
nitisinone
03
Conditions
oculocutaneous albinism type 1B (OCA1B)
Beyond the preview
Go deeper on NCT01838655.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01838655.